Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Truist Securities Analyst Reaffirms Hold Rating on Sunrun with Updated Price Target

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Truist Securities analyst Jordan Levy recently reaffirmed a Hold rating on Sunrun (NASDAQ: RUN) and adjusted the price target to $14 on February 26, 2024. This update comes after a previous downgrade from Buy to Hold with a price target of $12 on October 4, 2023. Back on May 9, 2023, Truist Securities had initially recommended a Buy for Sunrun before the subsequent adjustments.

RUN Stock Shows Positive Momentum on February 26, 2024: A Promising Sign for Investors

On February 26, 2024, Run stock (RUN) showed some positive momentum in its performance. Despite trading near the bottom of its 52-week range and below its 200-day simple moving average, the stock managed to see a slight increase in its price.

At the opening of the market, RUN was priced at $11.71, which was $0.19 lower than its previous close. However, throughout the trading day, the stock saw a price increase of $0.02, resulting in a 0.17% rise in its value since the market last closed.

While the increase may seem small, it is a positive sign for investors as it shows that there is some upward movement in the stock’s performance. This could be attributed to various factors such as positive news about the company, changes in market conditions, or investor sentiment.

It is important to note that even though the stock is trading near the bottom of its 52-week range, this does not necessarily mean that it is a bad investment. Investors should consider other factors such as the company’s financial health, growth prospects, and industry trends before making any investment decisions.

Overall, the slight increase in RUN stock on February 26, 2024, is a positive sign for investors. It will be interesting to see how the stock performs in the coming days and whether it can sustain this upward momentum.

Run Stock Performance Review: Flat Revenue, Improved Net Income, and Increased EPS on February 26, 2024

On February 26, 2024, Run stock experienced mixed performances based on the financial data provided by CNN Money. Total revenue for Run stood at $2.26 billion for the past year, remaining flat compared to the previous year. Similarly, total revenue for the last quarter was $516.59 million, also holding flat since the previous quarter.

In terms of net income, Run reported a net loss of $1.60 billion for the past year, representing a significant decrease of 1025.44% compared to the previous year. However, the net loss for the last quarter improved to $350.12 million, indicating a 67.26% increase from the previous quarter.

Earnings per share (EPS) for Run showed a similar trend. The EPS for the past year was -$7.41, reflecting a decrease of 1036.19% compared to the previous year. On the other hand, the EPS for the last quarter improved to -$1.60, showing a 67.43% increase from the previous quarter.

Overall, Run stock performances on February 26, 2024, demonstrated a mixed picture with flat total revenue, improved net income from the previous quarter, and an increase in earnings per share. Investors may want to closely monitor Run’s financial performance in the coming quarters to assess its long-term growth potential.

Tags: RUN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
MMM stock news

Analysts Bullish on AerCap Holdings with Positive Rating and Increased Price Target

Biotechnology Stock Bull Market

Title Request for Access to Google Docs Content

Healthcare cloud based

R1 RCM Stock Surges Following Lucrative Acquisition Offer

Recommended

Oracle Stock

Oracle Shares Face Sector-Wide Pressure Despite Solid Long-Term Chart

7 months ago
Telecommunications Industry stock Trading

Globalstar Forecasts Strong Financial Performance and Growth Initiatives for 2024

2 years ago
Pulmonx Corp Stock

Pulmonx Shares Surge on Leadership Shakeup and Upbeat Forecast

5 months ago
Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Trending

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

by Jackson Burston
March 25, 2026
0

The healthcare technology company Evolent Health is making a strategic push into artificial intelligence, appointing a seasoned...

MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase
  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com